European Generic medicines Association Company Profile

04:54 EDT 22nd September 2018 | BioPortfolio

The EGA is the official representative body of the European generic pharmaceutical industry, which is at the forefront of providing high-quality affordable medicines to millions of Europeans and stimulating competitiveness and innovation in the pharmaceutical sector.


Rue d'Arlon, 15


Phone: 32 (0)2 736 84 11
Fax: 32 (0)2 736 74 38

News Articles [3193 Associated News Articles listed on BioPortfolio]

North American generics makers call for rejection of new exclusivity period for biologics

First two CAR-T cell medicines recommended for approval in the European Union

The European Medicines Agency (EMA) has recommended the first two marketing authorisations for chimeric antigen receptors (CAR) T-cells medicines in the European Union (EU). Kymriah (tisagenlecleucel...

Switching to biosimilar and generic medicines saved the NHS over £300m in a year

NHS England saved £324m in 2017/2018 by switching from using ten “expensive” medicines to “better value and equally effective” alternatives, mainly generic and biosimilar medicines, NHS Impr...

EU makes it easier for companies to produce generic medicines for export

BRUSSELS (Reuters) - The European Commission on Monday proposed to change intellectual property rules to let pharmaceutical companies produce generic drugs for export to countries and regions where th...

Portugal increases use of generics for treatment of cardiovascular diseases

In Portugal, the use of medicines for cardiovascular system increased nearly two-fold between 2000 and 2010. As such, over a quarter of the overall expenditure on medicines during these years went tow...

NPA asked to lobby wholesalers to limit generic price rises

The National Pharmacy Association has been asked to lobby wholesalers to limit generic medicines price increases by a local pharmaceutical committee.

NPA asked to lobby government to limit generic price rises

The National Pharmacy Association has been asked to lobby the government to limit generic medicines price increases by a local pharmaceutical committee.

Generics applications under review by EMA – June 2018

Generic medicines in Europe can be approved either centrally via the European Medicines Agency (EMA) or nationally via the local regulatory body [1]. Approval by EMA takes place by using a centralized...

PubMed Articles [3576 Associated PubMed Articles listed on BioPortfolio]

The Association Between Patient Sociodemographic Characteristics and Generic Drug Use: A Systematic Review and Meta-analysis.

Generic drugs are bioequivalent and cost-effective alternatives to brand drugs. In 2014, $254 billion was saved because of the use of generic drugs in the United States.

Delays in completion and results reporting of clinical trials under the Paediatric Regulation in the European Union: A cohort study.

Few medicines have been approved for children, leading to rates of off-label prescribing reported to be as high as 90%. In 2007, the European Union adopted the Paediatric Regulation, which mandates th...

A cost analysis of the psychotropic medicines sold in the jan aushadhi generic drug stores in India.

Comparison of Compounded, Generic, and Innovator-Formulated Itraconazole in Dogs and Cats.

The triazole antifungal itraconazole may be cost prohibitive in brand name form; therefore, compounded and generic products are often used as alternatives. Itraconazole blood concentrations have not b...

Does consumer medicines interest reflect medicines use? An Australian observational study comparing medicines call center queries with medicines use.

Consumers have questions about their medication but the nature of these concerns and how they reflect medication use is unknown.

Clinical Trials [2809 Associated Clinical Trials listed on BioPortfolio]

Characterization of Epilepsy Patients BEEP 2b

Some epilepsy patients are described as GB when they have worsened seizures or side effects related to switching between brand name and generic, or between generic antiepileptic drug (AED)...

Bioequivalence Study of Generic GPO Saquinavir and Norvir® Versus Invirase® and Norvir®

The previous two studies of generic GPO saquinavir failed to prove bioequivalence. In this study the bio-equivalence will be investigated in healthy Thai volunteers, to see whether the gen...

Comparison of Blood Pressure Control Achieved in Antihypertensive or Generic Drugs in Moderate to Severe Hypertensive Patients

Despite a large diffusion for generic anti-hypertensive, they are not currently used. Clinical validation studies could be better to convince users and prescribers than pharmacologic vali...

TDM of Generic Lopinavir/Ritonavir 200/50 mg

Evaluating the bioavailibility safety and efficacy of the generic LPV/RTV 200/50 mg tablet formulation in a 400/100 mg BID dose in Thai HIV infected individuals.

Pharmacokinetic Parameters of Innovative Valganciclovir Versus Generic Valganciclovir

Cytomegalovirus (CMV) is the most common opportunistic viral pathogen in solid organ transplant receptors (SOTR). In Mexico, the experience using generic immunosuppressants have been demon...

Companies [2592 Associated Companies listed on BioPortfolio]

European Generic medicines Association

The EGA is the official representative body of the European generic pharmaceutical industry, which is at the forefront of providing high-quality affordable medicines to millions of Europeans and stimu...

European Medicines Agency

European Medicines Agency (EMEA) is a decentralised body of the European Union with headquarters in London.ts main responsibility is the protection and promotion of public and animal health, through t...

Mayne Pharma (USA) Inc

Mayne Pharma is an international leader in injectably generic and specialty pharmaceuticals and cost effective products. We focus on the research, development, manufacture, marketing and distribution ...

European Bioplastics e.V

The association "European Bioplastics", registered in 2006, is the European branch association representing industrial manufacturers, processors and users of bioplastics and biodegradable polymers (B...

GIRP, "Groupement International de la Répartition Pharmaceutique"

GIRP, "Groupement International de la Répartition Pharmaceutique" or in English "European Association of Pharmaceutical Full-line Wholesalers", is the umbrella organisation of pharmaceutical full-lin...

More Information about "European Generic medicines Association" on BioPortfolio

We have published hundreds of European Generic medicines Association news stories on BioPortfolio along with dozens of European Generic medicines Association Clinical Trials and PubMed Articles about European Generic medicines Association for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of European Generic medicines Association Companies in our database. You can also find out about relevant European Generic medicines Association Drugs and Medications on this site too.

Quick Search


Relevant Topic

Generics Drugs
A generic drug (generic drugs, short: generics) is a drug defined as "a drug product that is comparable to brand/reference listed drug product in dosage form, strength, route of administration, quality and performance characteristics, and intended u...

Corporate Database Quicklinks

Searches Linking to this Company Record